Navigation Links
Discovery Labs Receives $30 Million Funding Commitment from Deerfield Management
Date:2/13/2013

WARRINGTON, Pa., Feb. 13, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that it has entered into a secured loan facility with Deerfield Management Company, L.P. (Deerfield) for up to $30.0 million in financing.  Deerfield is a leading healthcare investment firm with more than $3.5 billion of assets currently under management. 

"We are encouraged by Deerfield's confidence in the potential of our transformative technology and business strategy," commented John G. Cooper , President and Chief Executive Officer at Discovery Labs.  "After considering a variety of financing options, we worked with Deerfield to structure a facility that aligns with our near-and long-term strategy to achieve important commercial, development and strategic milestones."

"We believe that SURFAXIN® and AEROSURF® could represent meaningful improvements in the care of premature infants with respiratory distress syndrome," commented William Slattery , Partner at Deerfield Management.  "Our goal with this facility is to strengthen Discovery Labs' financial position in a minimally dilutive way, and build a long-term relationship that helps advance these important programs for neonatal medicine."

Under terms of the facility, Deerfield committed to advance $30 million in 2013: $10 million immediately following execution of the facility agreement and $20 million upon the first commercial sale of SURFAXIN.  The loan matures six years from the date of the facility agreement and may
'/>"/>

SOURCE Discovery Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Chicago to Welcome Data Science, Big Data and Data Mining Leaders at the 19th International ACM Knowledge Discovery and Data Mining Conference, KDD 2013
2. Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40
3. Discovery in synthetic biology takes us a step closer to new industrial revolution
4. Automated design for drug discovery
5. Japan Bioinformatics Announces Study on Leading Mapping Tools for DNA Mutation Discovery
6. Research discovery could revolutionize semiconductor manufacture
7. Stem Cell Pioneer Recognized for 20 Years of Discovery and Innovation
8. Discovery could hold the key to super-sensory hearing
9. Sweet diesel! Discovery resurrects process to convert sugar directly to diesel
10. New discovery shows promise in future speed of synthesizing high-demand nanomaterials
11. UCF nanoparticle discovery opens door for pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... YORK , September 2, 2014 ... Study on Membrane Technology in Pharmaceutical, Biopharma and Life ... Highest Growth by 2019" the global membrane technology market for pharmaceutical, ... million in 2014 and is expected to grow at ... reach an estimated value of USD 10,886.0 million in ...
(Date:9/2/2014)... Sept. 2, 2014  TransCelerate BioPharma Inc. ("TransCelerate") ... approach for protecting personal data in Clinical Study ... and others. The document describes an approach to ... CSRs and other related clinical trial documents, and ... goal of the TransCelerate CSR Redaction approach is ...
(Date:9/2/2014)... -- Technology Applications International Corporation (the "Company" or "NUUU")(OTC BB: ... Inc. has signed an additional exclusive licensing agreement with ... Johnson Space Center in Houston , ... Charles J. Scimeca , NUUU,s ... latest, exclusive agreement with NASA. In addition to our ...
(Date:9/2/2014)... Myriant Corporation, a global renewable chemicals ... agreement with Azelis Group, a specialty chemicals distribution ... in the Nordics, Benelux, France, Iberia, Italy, the ... industrial and base chemicals markets. , “As a ... chemical portfolio with extensive distribution networks providing Myriant ...
Breaking Biology Technology:Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 2TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 3Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid 2
... DCGN ) announced that on February 2, 2009, ... (the "Panel") stating that the Panel,will transfer the listing ... the Nasdaq Capital Market, effective at the open of ... Capital Market, which is,one of the three market tier ...
... Health,Inc. (Nasdaq: GHDX ) today reported financial results ... 31, 2008. , Total revenue for ... $19.3 million in the fourth quarter of 2007. Product ... in the fourth,quarter of 2008, an increase of 60 percent, ...
... Abt Associates announced that Ricky Takai, Ph.D., has ... brief orientation to the firm, Dr. Takai will become ... 2009. Dr. Takai brings his more than 20 ... evaluation studies in the field of education to the ...
Cached Biology Technology:deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market 2deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 2Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 4Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 5Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 6Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 7Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 8Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 9Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates 2
(Date:9/2/2014)... by researchers at the University of Warwick in the ... published in the Journal Early Human Development , ... in hospital after birth and the use of mechanical ... preterm children. , Mathematic abilities are crucial for lifelong ... very preterm children. Earlier studies of children who are ...
(Date:9/2/2014)... breast milk is considered the most ideal source ... played a critical role in the evolution and ... human milk contains a large number of bacterial ... phenomenon comes as no surprise to scientists and ... is considered to be the result of co-evolutionary ...
(Date:9/2/2014)... In the battle between our immune systems and ... bacteria-killing viruses known as phages. In a new study, ... Health, Haiti,s National Public Health Laboratory, and elsewhere, report ... their virulence in order to survive. Importantly, the study ... cholera,s mutational escape from phage predation occurs during human ...
Breaking Biology News(10 mins):Mechanical ventilation a key indicator for pre-term children's math problems 2Are human breast milk microbiome 'neutral'? 2Are human breast milk microbiome 'neutral'? 3War between bacteria and phages benefits humans 2War between bacteria and phages benefits humans 3
... Medicine (BUSM) have brought attention to the potential health impacts ... brown seaweed soup. Seaweed is a known source of dietary ... on the iodine content in Korean seaweed soup. Written ... Thyroid and published online, the authors discuss the adverse ...
... investigation into the underlying causes of sudden cardiac death (SCD) ... the United States researchers have discovered a variation in ... increase in a person,s risk of SCD. The new ... region along the genome containing three genes previously unknown to ...
... useful strategy for helping prevent the development of panic and ... with an intense fear of the nausea, racing heart, dizziness, ... known as "high anxiety sensitivity" reacted with less anxiety ... high levels of physical activity, said researchers at Southern Methodist ...
Cached Biology News:BUSM researchers urge awareness of dietary iodine intake in postpartum Korean-American women 2Johns Hopkins researchers identify new genetic risk factor for sudden cardiac death 2Study: People at risk for panic buffered from stressor by high levels of physical activity 2Study: People at risk for panic buffered from stressor by high levels of physical activity 3
... For nucleofection of optimized cell lines in ... the nucleofection parameters. Nucleofector Kits are only ... Different cell lines can be transfected with ... are given in brackets in percent (Efficiency ...
... Human Pathogenic Viruses The National ... preserves well characterised, authenticated human ... facility, and NCPV is able ... nucleic acids derived from them, ...
B-FABP (FL-132)...
... a highly purified preparation of the catalytic ... which recognizes the identical cleavage site as ... enzymatic activity (1). Novagen&'s enzyme is produced ... the highest activity available, and is qualified ...
Biology Products: